Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Falconi

Showing results (351-360 of 639) with videos related to

Pageof 64
Sort By:
Endocrine-Related Cancer|October 5, 2016
mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumorsSimona Falletta, Stefano Partelli, Corrado Rubini, et al.
Annals of Surgery|February 10, 2010
Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratioStefano Partelli, Carlos Fernandez-Del Castillo, Claudio Bassi, et al.
Updates in Surgery|May 11, 2026
A risk-based framework to support conversion decision-making during minimally invasive left pancreatectomy: results from a multicentre registrySalvatore Paiella, Matteo De Pastena, Erica Secchettin, et al.
Journal for Immunotherapy of Cancer|February 15, 2019
The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancerEmanuela Brunetto, Lucia De Monte, Gianpaolo Balzano, et al.
JAMA Network Open|November 30, 2020
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous NeoplasmsGabriele Capurso, Stefano Crippa, Giuseppe Vanella, et al.
Surgical Endoscopy|August 3, 2019
Development of a conceptual framework of recovery after abdominal surgeryRoshni Alam, Joel Montanez, Susan Law, et al.
Plos One|May 23, 2018
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasmsRossana Berardi, Mariangela Torniai, Stefano Partelli, et al.
Anticancer Research|October 1, 2021
Adjuvant Radiotherapy in Patients With Pancreatic Adenocarcinoma. Is It Still Appealing in Clinical Trials? A Meta-analysis and Review of the LiteratureFrancesco Pasqualetti, Aldo Sainato, Riccardo Morganti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 2, 2024
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancerGaetano Lauri, Laura Apadula, Livia Archibugi, et al.
Neuroendocrinology|December 22, 2007
Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primaryThomas Steinmüller, Reza Kianmanesh, Massimo Falconi, et al.
Pageof 64

Showing results (351-360 of 639) with videos related to

Sort By:
Pageof 64
Endocrine-Related Cancer|October 5, 2016
mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumorsSimona Falletta, Stefano Partelli, Corrado Rubini, et al.
Annals of Surgery|February 10, 2010
Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratioStefano Partelli, Carlos Fernandez-Del Castillo, Claudio Bassi, et al.
Updates in Surgery|May 11, 2026
A risk-based framework to support conversion decision-making during minimally invasive left pancreatectomy: results from a multicentre registrySalvatore Paiella, Matteo De Pastena, Erica Secchettin, et al.
Journal for Immunotherapy of Cancer|February 15, 2019
The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancerEmanuela Brunetto, Lucia De Monte, Gianpaolo Balzano, et al.
JAMA Network Open|November 30, 2020
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous NeoplasmsGabriele Capurso, Stefano Crippa, Giuseppe Vanella, et al.
Surgical Endoscopy|August 3, 2019
Development of a conceptual framework of recovery after abdominal surgeryRoshni Alam, Joel Montanez, Susan Law, et al.
Plos One|May 23, 2018
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasmsRossana Berardi, Mariangela Torniai, Stefano Partelli, et al.
Anticancer Research|October 1, 2021
Adjuvant Radiotherapy in Patients With Pancreatic Adenocarcinoma. Is It Still Appealing in Clinical Trials? A Meta-analysis and Review of the LiteratureFrancesco Pasqualetti, Aldo Sainato, Riccardo Morganti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 2, 2024
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancerGaetano Lauri, Laura Apadula, Livia Archibugi, et al.
Neuroendocrinology|December 22, 2007
Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primaryThomas Steinmüller, Reza Kianmanesh, Massimo Falconi, et al.
Pageof 64